COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,785 Articles (22,523 medRxiv, 8,262 bioRxiv)

Most recent first Previous |  Page 1712: Articles 17111-17120  | Next

A Comparison of Performance for Different SARS-Cov-2 Sequencing Protocols
Bermudez, J.
10.1101/2021.03.01.433428 — Posted: 2021-03-01
The E3 Ubiquitin Ligase RNF5 Facilitates SARS-CoV-2 Membrane Protein-Mediated Virion Release
Yuan, Z., Ding, B.
10.1101/2021.02.28.433287 — Posted: 2021-03-01
Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell
Puray-Chavez, M., Lapak, K. M., Schrank, T. P., Elliott, J. L., Bhatt, D. P., Agajanian, M. J., Jasuja, R., Lawson, D. Q., Davis, K., Rothlauf, P. W., Jo, H., Lee, N., Tenneti, K., Eschbach, J. E., Shema Mugisha, C., Vuong, H. R., Bailey, A. L., Hayes, D. N., Whelan, S. P. J., Horani, A., Brody, S. L., Goldfarb, D., Major, M. B., Kutluay, S. B.
10.1101/2021.03.01.433431 — Posted: 2021-03-01
Negligible impact of SARS-CoV-2 variants on CD4+ and CD8+ T cell reactivity in COVID-19 exposed donors and vaccinees.
Tarke, A., Sidney, J., Methot, N., Zhang, Y., Dan, J. M., Goodwin, B., Rubiro, P., Sutherland, A., da Silva Antunes, R., Fraizer, A., Rawlings, S. A., Smith, D. M., Peters, B., Scheuermann, R. H., Weiskopf, D., Crotty, S., Grifoni, A., Sette, A.
10.1101/2021.02.27.433180 — Posted: 2021-03-01 Discussion: Onsite | Offsite
Reduced antibody cross-reactivity following infection with B.1.1.7 than with parental SARS-CoV-2 strains
Faulkner, N., Ng, K., Wu, M., Harvey, R., Hussain, S., Greco, M., Bolland, W., Warchal, S., Margaritis, M., Paraskevopoulou, S., Heaney, J., Rickman, H., Houlihan, C., Spyer, M., Frampton, D., Byott, M., de Oliveira, T., Sigal, A., Kjaer, S., Swanton, C., Gandhi, S., Beale, R., Gamblin, S., Mccauley, J., Daniels, R., Howell, M., Bauer, D., Nastouli, E., Kassiotis, G.
10.1101/2021.03.01.433314 — Posted: 2021-03-01
In vitro screening of herbal medicinal products for their supportive curing potential in the context of SARS-CoV-2
Tran, H., Peterburs, P., Seibel, J., Abramov-Sommariva, D., Lamy, E.
10.1101/2021.03.01.433344 — Posted: 2021-03-01
Risk factors for illness severity among pregnant women with confirmed SARS-CoV-2 infection - Surveillance for Emerging Threats to Mothers and Babies Network, 20 state, local, and territorial health departments, March 29, 2020 -January 8, 2021
Galang, R. R., Newton, S. M., Woodworth, K. R., Griffin, I., Oduyebo, T., Sancken, C. L., O'Malley Olsen, E., Aveni, K., Wingate, H., Shephard, H., Fussman, C., Alaali, Z. S., Siebman, S., Halai, U.-A., Delgado Lopez, C., Barton, J., Lush, M., Patrick, P. H., Schlosser, L., Sokale, A., Chaudhary, I., Reynolds, B., Sowunmi, S., Gaarenstroom, N., Read, J. S., Chicchelly, S., de Wilde, L., Azziz-Baumgartner, E., Hall, A. J., Tong, V. T., Ellington, S., Gilboa, S. M., CDC COVID-19 Response Pregnancy and Infant Linked Outcomes Team
10.1101/2021.02.27.21252169 — Posted: 2021-03-01
Trends in Thoracic Impedance and Arrhythmia Burden Among Patients with Implanted Cardiac Defibrillators During the COVID-19 Pandemic
Lu, Y., Murugiah, K., Jones, P., Caraballo, C., Mahajan, S., Massey, D., Rezwan, A., Bader, E., Krumholz, H.
10.1101/2021.02.27.21252559 — Posted: 2021-03-01
Physical Activity Patterns Among Patients with Intracardiac Remote Monitoring Devices Before, During, and After COVID-19-related Public Health Restrictions
Lu, Y., Murugiah, K., Jones, P., Massey, D., Mahajan, S., Caraballo, C., Rezwan, A., Bader, E., Krumholz, H.
10.1101/2021.02.27.21252558 — Posted: 2021-03-01
Effect of SARS-CoV-2 proteins on vascular permeability
Rauti, R., Shahoha, M., Leichtmann-Bardoogo, Y., Nasser, R., Tamir, R., Miller, V., Babich, T., Shaked, K., Ehrlich, A., Ioannidis, K., Nahmias, Y., Sharan, R., Ashery, U., Maoz, B. M.
10.1101/2021.02.27.433186 — Posted: 2021-03-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).